Peptide療法的全球市場規模：給藥途徑、類型、用途、按地區預測（2022-2028）

癌症和代謝紊亂發病率的增加、新藥的推出以及醫療保健活動支出的增加是全球市場增長的重要推動因素。

然而，在 2022 年至 2028 年的預測期內，藥物批准的嚴格監管負擔和藥物開發的高成本預計將阻礙市場增長。此外，預計在預測期內，研發活動的增加和技術進步將推動市場需求。

本報告對全球Peptide治療藥物市場進行研究和分析，並提供市場趨勢、競爭狀況、細分市場/地區市場分析、主要公司概況等系統資訊。

目錄

第 1 章執行摘要

第 2 章全球Peptide治療市場的定義和範圍

第 3 章全球Peptide治療市場動態

• Peptide治療藥物市場影響分析（2020-2028）

第 4 章全球Peptide治療市場行業分析

• 波特五力模型
• PEST 分析
• 投資採用模式
• 分析師建議和結論
• 主要投資機會
• 關鍵成功策略

第 5 章風險評估：COVID-19 的影響

• 評估 COVID-19 對行業的整體影響
• COVID-19 前後的市場情景

第 6 章全球Peptide治療市場：按管理途徑

• 市場快照
• 市場表現/潛力分析：按管理途徑
• 市場估計和預測：按管理途徑（2018-2028 年）
• 細分分析
  • 腸外途徑
  • 口服途徑
  • 經肺
  • 粘膜
  • 其他

第 7 章全球Peptide治療市場：按類型

• 市場快照
• 市場表現/潛力分析：按類型
• 市場估計和預測：按類型（2018-2028 年）
• 細分分析
  • 通用
  • 新藥

第 8 章全球Peptide治療市場：按用途

• 市場快照
• 市場表現/潛力分析：按應用
• 市場估計和預測：按應用分類 (2018-2028)
• 細分分析
  • 癌症
  • 心血管疾病
  • 中樞神經系統
  • 傳染病
  • 呼吸系統疾病
  • 其他用途

第 9 章全球Peptide治療市場：區域分析

• 區域市場概況
• 北美
  • 美國
  • 加拿大
• 歐洲
  • 英國
  • 德國
  • 法國
  • 西班牙
  • 義大利
  • 其他歐洲
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 澳大利亞
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 墨西哥
• 其他領域

第 10 章競爭資訊

• 主要市場策略
• 公司簡介
  • Eli Lilly and Company
  • Pfizer, Inc.
  • Amgen, Inc.
  • Takeda Pharmaceutical Company Limited
  • Teva Pharmaceuticals Industries Ltd.
  • Lonza Inc.
  • Sanofi
  • Bristol-Myers Squibb(BMS)
  • AstraZeneca PLC
  • Novartis AG

第 11 章調查過程

Global Peptide Therapeutics Market is valued at approximately USD XX million in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2028. Peptide therapeutics are a type of polypeptides or peptides that is primarily used to cure a wide range of diseases such as cancer, cardiovascular diseases, infections, respiratory disorders, and many others. The growing incidences of cancer and metabolic disorders, the introduction of novel drugs, and increasing spending on healthcare activities are some prominent factors excelling the global market growth. For instance, according to the National Cancer Institute, the number of cancer patients is expected to rise to 29.5 million cases by the year 2040 from 18.1 million cases in the year 2018. Consequentially, the growing cases of cancer are fueling the demand for the Peptide Therapeutics, which, in turn, augments the market growth across the globe. However, the imposition of stringent regulations for drug approval and the high cost of developing drugs impede the growth of the market over the forecast period of 2022-2028. Also, the rising research and development activities and technological advancements are anticipated to act as catalyzing factors for the market demand during the forecast period.

The key regions considered for the global Peptide Therapeutics Market study include: Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to the growth of the biotechnology industry and rising focus on the introduction of novel drugs. Whereas, Asia-Pacific is anticipated to exhibit the highest CAGR over the forecast period 2022-2028. Factors such as the increasing investments in research and development activities, and the rising incidences of cancer, would create lucrative growth prospects for the Peptide Therapeutics Market across the Asia-Pacific region.

Major market players included in this report are:

• Eli Lilly and Company
• Pfizer, Inc.
• Amgen, Inc.
• Takeda Pharmaceutical Company Limited
• Teva Pharmaceuticals Industries Ltd.
• Lonza Inc.
• Sanofi
• Bristol-Myers Squibb (BMS)
• AstraZeneca PLC
• Novartis AG

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Route of Administration:

• Parenteral Route
• Oral Route
• Pulmonary
• Mucosal
• Others

By Type:

• Generic
• Innovative

By Application:

• Cancer
• Cardiovascular Diseases
• Central Nervous Systems
• Infections
• Respiratory Disorders
• Other Applications

By Region:

• North America
  • U.S.
  • Canada

• Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE

• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC

• Latin America
  • Brazil
  • Mexico

• Rest of the World

Furthermore, years considered for the study are as follows:

• Historical year - 2018, 2019, 2020
• Base year - 2021
• Forecast period - 2022 to 2028

Target Audience of the Global Peptide Therapeutics Market in Market Study:

• Key Consulting Companies & Advisors
• Large, medium-sized, and small enterprises
• Venture capitalists
• Value-Added Resellers (VARs)
• Third-party knowledge providers
• Investment bankers
• Investors

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Million)
  • 1.2.1. Peptide Therapeutics Market, by Region, 2020-2028 (USD Million)
  • 1.2.2. Peptide Therapeutics Market, by Route of Administration, 2020-2028 (USD Million)
  • 1.2.3. Peptide Therapeutics Market, by Type, 2020-2028 (USD Million)
  • 1.2.4. Peptide Therapeutics Market, by Application, 2020-2028 (USD Million)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Peptide Therapeutics Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Scope of the Study
  • 2.2.2. Industry Evolution
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Peptide Therapeutics Market Dynamics

• 3.1. Peptide Therapeutics Market Impact Analysis (2020-2028)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Growing incidences of cancer and metabolic disorder
    • 3.1.1.2. Introduction of novel drugs
  • 3.1.2. Market Challenges
    • 3.1.2.1. Imposition of stringent regulations for drug approval
    • 3.1.2.2. High cost of developing drugs
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Rising research and development activities
    • 3.1.3.2. Technological advancements

Chapter 4. Global Peptide Therapeutics Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
  • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2028)
• 4.2. PEST Analysis
  • 4.2.1. Political
  • 4.2.2. Economical
  • 4.2.3. Social
  • 4.2.4. Technological
• 4.3. Investment Adoption Model
• 4.4. Analyst Recommendation & Conclusion
• 4.5. Top investment opportunity
• 4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

• 5.1.1. Assessment of the overall impact of COVID-19 on the industry
• 5.1.2. Pre COVID-19 and post COVID-19 market scenario

Chapter 6. Global Peptide Therapeutics Market, by Route of Administration

• 6.1. Market Snapshot
• 6.2. Global Peptide Therapeutics Market by Route of Administration, Performance - Potential Analysis
• 6.3. Global Peptide Therapeutics Market Estimates & Forecasts by Route of Administration, 2018-2028 (USD Million)
• 6.4. Peptide Therapeutics Market, Sub Segment Analysis
  • 6.4.1. Parenteral Route
  • 6.4.2. Oral Route
  • 6.4.3. Pulmonary
  • 6.4.4. Mucosal
  • 6.4.5. Others

Chapter 7. Global Peptide Therapeutics Market, by Type

• 7.1. Market Snapshot
• 7.2. Global Peptide Therapeutics Market by Type, Performance - Potential Analysis
• 7.3. Global Peptide Therapeutics Market Estimates & Forecasts by Type, 2018-2028 (USD Million)
• 7.4. Peptide Therapeutics Market, Sub Segment Analysis
  • 7.4.1. Generic
  • 7.4.2. Innovative

Chapter 8. Global Peptide Therapeutics Market, by Application

• 8.1. Market Snapshot
• 8.2. Global Peptide Therapeutics Market by Application, Performance - Potential Analysis
• 8.3. Global Peptide Therapeutics Market Estimates & Forecasts by Application, 2018-2028 (USD Million)
• 8.4. Peptide Therapeutics Market, Sub Segment Analysis
  • 8.4.1. Cancer
  • 8.4.2. Cardiovascular Diseases
  • 8.4.3. Central Nervous Systems
  • 8.4.4. Infections
  • 8.4.5. Respiratory Disorders
  • 8.4.6. Other Applications

Chapter 9. Global Peptide Therapeutics Market, Regional Analysis

• 9.1. Peptide Therapeutics Market, Regional Market Snapshot
• 9.2. North America Peptide Therapeutics Market
  • 9.2.1. U.S. Peptide Therapeutics Market
    • 9.2.1.1. Route of Administration breakdown estimates & forecasts, 2018-2028
    • 9.2.1.2. Type breakdown estimates & forecasts, 2018-2028
    • 9.2.1.3. Application breakdown estimates & forecasts, 2018-2028
  • 9.2.2. Canada Peptide Therapeutics Market
• 9.3. Europe Peptide Therapeutics Market Snapshot
  • 9.3.1. U.K. Peptide Therapeutics Market
  • 9.3.2. Germany Peptide Therapeutics Market
  • 9.3.3. France Peptide Therapeutics Market
  • 9.3.4. Spain Peptide Therapeutics Market
  • 9.3.5. Italy Peptide Therapeutics Market
  • 9.3.6. Rest of Europe Peptide Therapeutics Market
• 9.4. Asia-Pacific Peptide Therapeutics Market Snapshot
  • 9.4.1. China Peptide Therapeutics Market
  • 9.4.2. India Peptide Therapeutics Market
  • 9.4.3. Japan Peptide Therapeutics Market
  • 9.4.4. Australia Peptide Therapeutics Market
  • 9.4.5. South Korea Peptide Therapeutics Market
  • 9.4.6. Rest of Asia Pacific Peptide Therapeutics Market
• 9.5. Latin America Peptide Therapeutics Market Snapshot
  • 9.5.1. Brazil Peptide Therapeutics Market
  • 9.5.2. Mexico Peptide Therapeutics Market
• 9.6. Rest of The World Peptide Therapeutics Market

Chapter 10. Competitive Intelligence

• 10.1. Top Market Strategies
• 10.2. Company Profiles
  • 10.2.1. Eli Lilly and Company
    • 10.2.1.1. Key Information
    • 10.2.1.2. Overview
    • 10.2.1.3. Financial (Subject to Data Availability)
    • 10.2.1.4. Product Summary
    • 10.2.1.5. Recent Developments
  • 10.2.2. Pfizer, Inc.
  • 10.2.3. Amgen, Inc.
  • 10.2.4. Takeda Pharmaceutical Company Limited
  • 10.2.5. Teva Pharmaceuticals Industries Ltd.
  • 10.2.6. Lonza Inc.
  • 10.2.7. Sanofi
  • 10.2.8. Bristol-Myers Squibb (BMS)
  • 10.2.9. AstraZeneca PLC
  • 10.2.10. Novartis AG

Chapter 11. Research Process

• 11.1. Research Process
  • 11.1.1. Data Mining
  • 11.1.2. Analysis
  • 11.1.3. Market Estimation
  • 11.1.4. Validation
  • 11.1.5. Publishing
• 11.2. Research Attributes
• 11.3. Research Assumption

LIST OF TABLES

• TABLE 1. Global Peptide Therapeutics Market, report scope
• TABLE 2. Global Peptide Therapeutics Market estimates & forecasts by Region 2018-2028 (USD Million)
• TABLE 3. Global Peptide Therapeutics Market estimates & forecasts by Route of Administration 2018-2028 (USD Million)
• TABLE 4. Global Peptide Therapeutics Market estimates & forecasts by Type 2018-2028 (USD Million)
• TABLE 5. Global Peptide Therapeutics Market estimates & forecasts by Application 2018-2028 (USD Million)
• TABLE 6. Global Peptide Therapeutics Market by segment, estimates & forecasts, 2018-2028 (USD Million)
• TABLE 7. Global Peptide Therapeutics Market by region, estimates & forecasts, 2018-2028 (USD Million)
• TABLE 8. Global Peptide Therapeutics Market by segment, estimates & forecasts, 2018-2028 (USD Million)
• TABLE 9. Global Peptide Therapeutics Market by region, estimates & forecasts, 2018-2028 (USD Million)
• TABLE 10. Global Peptide Therapeutics Market by segment, estimates & forecasts, 2018-2028 (USD Million)
• TABLE 11. Global Peptide Therapeutics Market by region, estimates & forecasts, 2018-2028 (USD Million)
• TABLE 12. Global Peptide Therapeutics Market by segment, estimates & forecasts, 2018-2028 (USD Million)
• TABLE 13. Global Peptide Therapeutics Market by region, estimates & forecasts, 2018-2028 (USD Million)
• TABLE 14. Global Peptide Therapeutics Market by segment, estimates & forecasts, 2018-2028 (USD Million)
• TABLE 15. Global Peptide Therapeutics Market by region, estimates & forecasts, 2018-2028 (USD Million)
• TABLE 16. U.S. Peptide Therapeutics Market estimates & forecasts, 2018-2028 (USD Million)
• TABLE 17. U.S. Peptide Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 18. U.S. Peptide Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 19. Canada Peptide Therapeutics Market estimates & forecasts, 2018-2028 (USD Million)
• TABLE 20. Canada Peptide Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 21. Canada Peptide Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 22. UK Peptide Therapeutics Market estimates & forecasts, 2018-2028 (USD Million)
• TABLE 23. UK Peptide Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 24. UK Peptide Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 25. Germany Peptide Therapeutics Market estimates & forecasts, 2018-2028 (USD Million)
• TABLE 26. Germany Peptide Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 27. Germany Peptide Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 28. RoE Peptide Therapeutics Market estimates & forecasts, 2018-2028 (USD Million)
• TABLE 29. RoE Peptide Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 30. RoE Peptide Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 31. China Peptide Therapeutics Market estimates & forecasts, 2018-2028 (USD Million)
• TABLE 32. China Peptide Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 33. China Peptide Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 34. India Peptide Therapeutics Market estimates & forecasts, 2018-2028 (USD Million)
• TABLE 35. India Peptide Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 36. India Peptide Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 37. Japan Peptide Therapeutics Market estimates & forecasts, 2018-2028 (USD Million)
• TABLE 38. Japan Peptide Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 39. Japan Peptide Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 40. RoAPAC Peptide Therapeutics Market estimates & forecasts, 2018-2028 (USD Million)
• TABLE 41. RoAPAC Peptide Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 42. RoAPAC Peptide Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 43. Brazil Peptide Therapeutics Market estimates & forecasts, 2018-2028 (USD Million)
• TABLE 44. Brazil Peptide Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 45. Brazil Peptide Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 46. Mexico Peptide Therapeutics Market estimates & forecasts, 2018-2028 (USD Million)
• TABLE 47. Mexico Peptide Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 48. Mexico Peptide Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 49. RoLA Peptide Therapeutics Market estimates & forecasts, 2018-2028 (USD Million)
• TABLE 50. RoLA Peptide Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 51. RoLA Peptide Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 52. Row Peptide Therapeutics Market estimates & forecasts, 2018-2028 (USD Million)
• TABLE 53. Row Peptide Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 54. Row Peptide Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 55. List of secondary sources, used in the study of global Peptide Therapeutics Market
• TABLE 56. List of primary sources, used in the study of global Peptide Therapeutics Market
• TABLE 57. Years considered for the study
• TABLE 58. Exchange rates considered

LIST OF FIGURES

List of figures

• FIG 1. Global Peptide Therapeutics Market, research methodology
• FIG 2. Global Peptide Therapeutics Market, market estimation techniques
• FIG 3. Global market size estimates & forecast methods
• FIG 4. Global Peptide Therapeutics Market, key trends 2021
• FIG 5. Global Peptide Therapeutics Market, growth prospects 2022-2028
• FIG 6. Global Peptide Therapeutics Market, porters 5 force model
• FIG 7. Global Peptide Therapeutics Market, pest analysis
• FIG 8. Global Peptide Therapeutics Market, value chain analysis
• FIG 9. Global Peptide Therapeutics Market by segment, 2018 & 2028 (USD Million)
• FIG 10. Global Peptide Therapeutics Market by segment, 2018 & 2028 (USD Million)
• FIG 11. Global Peptide Therapeutics Market by segment, 2018 & 2028 (USD Million)
• FIG 12. Global Peptide Therapeutics Market by segment, 2018 & 2028 (USD Million)
• FIG 13. Global Peptide Therapeutics Market by segment, 2018 & 2028 (USD Million)
• FIG 14. Global Peptide Therapeutics Market, regional snapshot 2018 & 2028
• FIG 15. North America Peptide Therapeutics Market 2018 & 2028 (USD Million)
• FIG 16. Europe Peptide Therapeutics Market 2018 & 2028 (USD Million)
• FIG 17. Asia Pacific Peptide Therapeutics market 2018 & 2028 (USD Million)
• FIG 18. Latin America Peptide Therapeutics Market 2018 & 2028 (USD Million)
• FIG 19. Global Peptide Therapeutics Market, company market share analysis (2021)